• Your shopping cart is empty!

  • CLSI NBS07-Ed1 (R2022)

CLSI NBS07-Ed1 (R2022)

Newborn Blood Spot Screening for Pompe Disease by Lysosomal Acid alpha-Glucosidase Activity Assays, 1st Edition, NBS07Ed1E

Clinical and Laboratory Standards Institute, 03/01/2017

Publisher: CLSI

File Format: PDF

$90.00$180.00


Published:01/03/2017

Pages:70

File Size:1 file , 2.9 MB

Note:This product is unavailable in Russia, Belarus

This report discusses the detection of Pompe disease (PD) by population-based newborn screening using dried blood spot specimens to measure acid α-glucosidase enzyme activity. Classic infantile-onset PD is a lethal disorder that is not evident at birth, and therapy effectiveness is improved by presymptomatic detection.

More CLSI standard pdf

CLSI H21-A5

CLSI H21-A5

Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays; Approved Guideline, Fifth Edition, H21-A5

$90.00 $180.00

CLSI H57-A

CLSI H57-A

Protocol for the Evaluation, Validation, and Implementation of Coagulometers; Approved Guideline, H57-A

$90.00 $180.00

CLSI M50-P

CLSI M50-P

Quality Control for Commercial Microbial Identification Systems, M50PE

$122.00 $244.95

CLSI C50-A

CLSI C50-A

Mass Spectrometry in the Clinical Laboratory: General Principles and Guidance; Approved Guideline, C50AE

$108.00 $216.35